Unichem Laboratories has received ANDA approval for its Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Glucophage XR Tablets, 500 mg and 750 mg, of EMD Serono Inc.

Metformin Hydrochloride Extended-Release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The product will be commercialized from Unichem's Goa plant.

The company is an international, integrated, speciality pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.